T

Tempest Therapeutics
D

TPST

1.06000
USD
0.01
(0.95%)
مغلق
حجم التداول
19,200
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
26,720,260
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Tempest Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.